NCT01631357View on ClinicalTrials.gov

Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

Non-small Cell Lung CancerSquamous Cell Carcinoma

Interventions

BIOLOGICAL

CIK cell

CIK cell injection

DRUG

Gemcitabine Injection

Gemcitabine injection

DRUG

Cisplatin injection

Trial Locations (1)

300060

Tianjin Medical University Cancer Institute and Hospital, Tianjin

All Listed Sponsors

lead

Tianjin Medical University Cancer Institute and Hospital

OTHER

NCT01631357 - Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer | Biotech Hunter | Biotech Hunter